Home About Us
Products Technology
Partnership Investing
Contact

Clinical Advisory Board

Michael Niederman, MD

Dr. Niederman is Professor of Medicine and Vice-Chairman of the Department of Medicine at the SUNY Stony Brook School of Medicine. A practicing pulmonologist for 30 years and a leading expert in hospital acquired pneumonia. He has authored over 300 peer-reviewed or review articles, is co-editor of the first and second editions of the textbook, Respiratory Infections: A Scientific Basis for Management and editor-in-chief of Clinical Pulmonary Medicine. He obtained his degree from Boston University School of Medicine, performed residency at Northwestern University Medical School and fellowship in Pulmonary and Critical Care at Yale University School of Medicine. Dr. Niederman is a Fellow of, and active member of The American College of Chest Physicians, The American College of Physicians and The American Thoracic Society.

Richard B. Moss, M.D.

Dr. Moss is professor of Pediatrics at Stanford University School of medicine and chief, pediatric pulmonology and allergy with over 150 scientific publications. He is the chair of the protocol review committee for the Cystic Fibrosis Therapeutics Development Network (TDN). Dr. Moss’s honors include The Best Doctors in America, America’s Top Pediatricians - Pulmonology and Professional of the Year by the Cystic Fibrosis Foundation (CFF). His research involves the immunoregulation of inflammation in cystic fibrosis and he has been involved in numerous CF clinical trials. One of his research interests is aerosol gene therapy for in vivo correction of genetic lung disease and new treatments for CF complications such as diabetes and osteoporosis.

Alan H Cohen, MD, FAAP, FCCP

Dr Cohen is a board certified Pediatric Pulmonologist and currently the Vice President, Clinical Development and Medical Affairs, Pulmonary, at MAP Pharmaceuticals, in Palo Alto, CA. He also holds an appointment as adjunct clinical faculty at Stanford University School of Medicine – in the Dept of Pediatric Pulmonology and Allergy. He is the author of over 100 peer reviewed articles, abstracts, platform presentations and book chapters in his areas of interest and expertise, including Cystic Fibrosis, Lung Transplantation, Infectious Disease and respiratory pathogens – such as RSV, influenza and molds. He was formerly the Senior Director of Medical Affairs at Medimmune, Inc – involved in drug discovery of monoclonal antibodies and vaccines. He has held faculty appointments at a number of prestigious centers of learning and healthcare including the Johns Hopkins School of Medicine, Morehouse School of Medicine, Washington University School of Medicine, as well as the University of Colorado / National Jewish Center for Immunology and Respiratory Diseases.

Lisa Saiman, M.D.

Clinical Consultant

Dr. Saiman is Professor of Clinical Pediatrics at Columbia University and Director of the CF Referral Center for Susceptibility and Synergy Studies. She has over 140 publications in infectious disease and cystic fibrosis.

Dr. Saiman is a member of the CF Foundation Clinical Research Committee and Principal investigator on numerous CF clinical trials including demonstrating efficacy of Azithromycin to treat CF lung infections.

Bruce K. Rubin, M.Engr., M.D., MBA

Dr.Rubin is Professor & Vice Chair of Pediatrics, Professor of Physiology & Pharmacology, & Professor of Biomedical Engineering at Wake Forest University with over 150 scientific publications. He is a Fellow of the Royal College of Physicians in Canada, the American College of Chest Physicians, and a member of the American Pediatric Association. He is the President of the International Congress of Pediatric Pulmonology. Dr. Rubin received the Alfred Soffer Award for Editorial Excellence 2004. He is listed in Who’s Who in Science and Engineering, Who’s Who in the United States, and The Best Doctors in America. Dr Rubin’s research is regulation of mucus clearance in health and disease and aerosol delivery of medications. He directs the only comprehensive Mucus Clearance Disorder’s clinic in the United States for the assessment & treatment of adults and children with difficulty to manage mucus problems.